2022
DOI: 10.1016/s2468-1253(22)00120-0
|View full text |Cite
|
Sign up to set email alerts
|

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 3 publications
0
1
0
Order By: Relevance
“…[6][7][8] In some countries, including the UK, immunosuppressed patients have been prioritised for third primary doses and booster doses of vaccine, 9 and in the UK, uptake of third doses amongst immunosuppressed patients with IBD has been reported at 79%. 10 Data about immunity following third vaccine doses in patients with IBD are limited, and interpretation is problematic due to a lack of healthy control participants or data about cellmediated immunity. 11 We have shown that a two-dose schedule of mRNA vaccine is associated with higher anti-SARS-CoV-2 spike antibody binding than two doses of adenovirus vector vaccine in the immunosuppressed population with IBD.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8] In some countries, including the UK, immunosuppressed patients have been prioritised for third primary doses and booster doses of vaccine, 9 and in the UK, uptake of third doses amongst immunosuppressed patients with IBD has been reported at 79%. 10 Data about immunity following third vaccine doses in patients with IBD are limited, and interpretation is problematic due to a lack of healthy control participants or data about cellmediated immunity. 11 We have shown that a two-dose schedule of mRNA vaccine is associated with higher anti-SARS-CoV-2 spike antibody binding than two doses of adenovirus vector vaccine in the immunosuppressed population with IBD.…”
Section: Introductionmentioning
confidence: 99%
“…Regarding age, the available evidence suggests that older individuals display greater adherence to vaccination [25][26][27][28][30][31][32]35]. This inclination can be attributed to the increased susceptibility of advanced age to COVID-19 complications, which is frequently accompanied by an increased prevalence of other underlying health conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Regarding gender, greater levels of compliance were noted among females [26,28,35], and various studies [25][26][27][28][30][31][32]35] indicated reduced hesitancy among older individuals. Social determinants have also emerged as significant factors.…”
Section: Pooled Analysismentioning
confidence: 99%
See 2 more Smart Citations